Show results for
Refine by
Industries served
Antigen Specificity Suppliers Serving Bhutan
82 companies found
Premium
based inMontigny-le-Bretonneux, FRANCE
Bertin Technologies is a French industrialist in scientific instrumentation that designs and manufactures, in France and in Europe, measurement, observation & detection systems and instruments for critical applications. Every day, Bertin ...
based inTehran, IRAN
Pars Isotope Co is a prominent supplier and producer of radioisotopes in Iran, catering widely to the medical and industrial sectors. As the sole provider in the region, the company focuses on radiopharmaceuticals used for both the diagnosis and ...
The PARS-LUTOPSMA kit is an innovative theranostic radiopharmaceutical developed by Parsisotope Company, designed specifically for the treatment of metastatic prostate cancer. This kit is notable for being the first of its kind ...
based inGroningen, NETHERLANDS
ViciniVax is a Dutch clinical stage biopharmaceutical company. It is a spin-off from the University Medical Center Groningen, the Netherlands, developing therapeutic cancer vaccines. Our first product candidate Vvax001, a therapeutic cancer vaccine ...
Our first product candidate Vvax001, a therapeutic cancer vaccine against (pre)malignant cervical lesions, is currently in clinical development. We outsource process development and GMP manufacturing to experienced CMO’s, leading to a first ...
based inVirum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
Reliable Identification of SARS-CoV-2-Specific T-Cell Responses. T Cells Take the Lead in COVID-19. A deeper understanding of viral-specific T-cell responses to COVID-19 is needed to explore vaccine responses, ...
based inIrvine, CALIFORNIA (USA)
Established in 1997 by a group of renowned scientists, GeneTex's corporate mission remains clear. While commercial polyclonal and monoclonal antibodies have driven progress in science and medicine since their introduction, the generation of reliable ...
Optimal dilutions/concentrations should be determined by the ...
based inDavis, CALIFORNIA (USA)
For over fifty years, the people of Antibodies Incorporated have dedicated themselves to supporting the life-enhancing, breakthrough work of scientists everywhere. We fulfill our mission with an extensive catalog of validated neuroscience antibodies ...
Custom antibody development is rarely "cookie cutter." Our Antibody Development Group will work with your price and technical requirements to tailor a project to your expected performance characteristics. ...
based inBinhai, CHINA
Genobio Pharmaceutical Co., Ltd. was established in 2014 and is one of the subsidiaries of Tianjin Era Biology Technology Co., Ltd. Genobio focuses on the development of marine organisms and is committed to serving as a provider and integrator of ...
based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
Cancer is the leading cause of death in Japan, with approximately 90% of those deaths said to be caused by solid ...
based inLeichhardt, AUSTRALIA
Atomo Diagnostics Limited is a global leader in the user-centered design of innovative, accurate and reliable rapid diagnostics. Atomo has developed the most consumer friendly platform available for rapid at-home testing. Our integrated testing ...
A fast, accurate point of care COVID-19 antigen test for the qualitative detection of nucleocapsid protein antigens specific to the SARS-CoV-2 virus. Utilising an anterior nasal swab specimen ...
based inCambridge, UNITED KINGDOM
Based in Cambridge, one of Europe's largest bioscience hubs, Biorbyt has a simple yet challenging mission: to provide the best service to the global scientific community. We achieve this by collaborating with the world’s finest researchers and ...
Plasma cells are specialised B lymphocytes that secrete antibodies (glycoproteins) in response to infection by antigens (toxins or foreign substances). Antibodies, also known as immunoglobulins (Ig), usually have a high affinity to ...
based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
Immatics is developing Adoptive Cell Therapies, which are designed to leverage the power of T cells to actively infiltrate tumor tissue and kill tumor cells in a specific and serial ...
based inBammental, GERMANY
We are experts in Blood Typing Reagents for Automated and Manual Applications. Forecast-free, fast and reliable, complying with the highest quality standards. We produce finished reagent bulk, unlabeled vials, OEM in customer design and our own ...
based inCambridge, UNITED ARAB EMIRATES
Founded in 2010, Sphere Fluidics is an established Life Sciences company, originally spun out from the University of Cambridge. We initially developed 25 patented products – biochips and specialist chemicals – which currently assist hundreds of ...
based inWarsaw, POLAND
Cormay Diagnostics represents a conglomerate of European companies specializing in in vitro diagnostics (IVD) and advanced technology solutions. Leveraging almost four decades of experience, Cormay combines its expertise in reagent manufacturing ...
The AURYX 90 Immunoassay System is a fully automated device designed for in vitro diagnostic analysis of various analytes such as antigens, antibodies, hormones, and specific proteins in human serum and plasma. This ...
based inPeachtree Corners, GEORGIA (US) (USA)
RayBiotech is a leading life sciences company providing proteomic discovery tools. RayBiotech has nearly 150 employees whose objectives are to provide excellent products and service worldwide to RayBiotech customers which include scientists in ...
Combining direct antigen-labeling technology with our vast library of array-validated antibodies, RayBiotech has created our largest antibody array to date: the Human L6000 Array. With the L-Series high density array platform, researchers can now ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
based inSovicille, ITALY
Sclavo Diagnostics International, an Italian company, developing, manufacturing and marketing In-Vitro diagnostics reagents and instruments for Clinical Chemistry, Specific and Urinary Proteins (Turbidimetry, Nephelometry), Coagulation, Serology, ...
Latex Agglutination Test for the identification of Staphylococcus aureus from primary strains. The positive reaction becomes evident after 5 seconds only even with Methicylin-resistant S. aureus ...
based inCarlton South, AUSTRALIA
Chimeric Therapeutics is a clinical stage cell therapy company focused on bringing the promise of cell therapy to life for more patients with cancer. We believe that cellular therapies have the promise to cure cancer not just delay disease ...
T cells are part of our adaptive immune system – the system that tailors the body’s response to specific pathogens. Rather than generically attack any antigens, T cells circulate until they encounter a ...
based inPleasanton, PENNSYLVANIA (USA)
10x Genomics is building tools for scientific discovery that reveal and address the true complexities of biology and disease. 10x Genomics products have been adopted by researchers around the world, including all of the top 100 global research ...
Single cell resolution to maximize biological ...
based inLondon, UNITED KINGDOM
Treos Bio is a clinical stage company introducing a disruptive computational technology to change the paradigm of cancer immunotherapy development by resolving the dual challenges of patient and tumor heterogeneity. We use proprietary therapeutic ...
Using our proprietary computational vaccine design technology, we have developed a PolyPEPI preventive peptide vaccine against COVID-19 (SARS-CoV-2). The design of PolyPEPI-SCoV-2 exploits our knowledge on genetic heterogeneity of individuals ...
